Skip to main content
SpringerLink
Log in

Prise en charge chirurgicale des patientes traitées par chimiothérapie néo-adjuvante pour cancer du sein

  • Conference paper
Cancer du sein

  • 247 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Références

  1. Aman U. Buzdar (2004) The Current state of Preoperative (Neoadjuvant) Hormonal Therapy for Breast Cancer. Breast Diseases: A Year Book Quaterly, vol. 15, no 3

    Google Scholar 

  2. Kaufmann M, Monckwitz G, Smith R et al. (2003) International Expert Panel on the Use of Primary (Preoperative) Systemic Treatment of Operable Breast Cancer: Review and Recommandations. Journal of Clinical Onocoly, vol 21, no 13 (July,1): 2600–8

    Article  Google Scholar 

  3. Schwartz GF, Hortobagyi GN and the Consensus Conference Committee (2004). Proceedings of the Consensus Conference on Neoadjuvant Chemotherapy in Carcinoma of the Breast, April 26–28, 2003, Philadelphia, Pennsylvania. Cancer June15, vol. 100, no 12

    Google Scholar 

  4. Anderson ED, Forrest AP, Hawkins RA et al. (1991) Primarys systemic therapy for operable breast cancer. BR J Cancer 63: 561–6

    PubMed  CAS  Google Scholar 

  5. Calais G, Berger C, Descamps P et al. (1994) Conservative treatment feasibility with induction chemotherapy, surgery, and radiotherapy for patients with breast carcinoma larger than 3 cm. Cancer 74: 1283–8

    PubMed  CAS  Google Scholar 

  6. Avril A, Faucher A, Bussières E et al. (1998) Résultats à 10 ans d’un essai randomisé de chimiothérapie néo-adjuvante dans les cancers du sein de plus de 3 cm. Chirurgie 123: 247–56

    Article  PubMed  CAS  Google Scholar 

  7. Uzan S et al. La chimiothérapie néo-adjuvante. Données à propos d’une série de 295 patientes prises en charge à l’hôpital Tenon (données en cours d’exploitation et de publication).

    Google Scholar 

  8. Fisher B, Bryant J, Wolmark N et al. (1998) Effect of preoperative chemotherapy on the outcome of women with operable breast cancer. J Clin Oncol 16: 2672–85

    PubMed  CAS  Google Scholar 

  9. van der Hage JA, van de Velde CJH, Julien JP et al. (2001) Peoperative chemotherapy in primary operable breast cancer: Results from the European Organization for Research and Treatment of Cancer Trial 10902. J Clin Oncol 19: 4224–37

    PubMed  Google Scholar 

  10. Jakesz R, for the ABCSG (2001) Comparison of pre-versus postoperative chemotherapy in breast cancer patients: Four-years results of Austrian Breast & Colorectal Cancer Study Group, ABCSGo Trial. 7 Proc am Soc Clin Oncol 20: 125

    Google Scholar 

  11. Le Bouedec G, Cure H, Charrier S et al. (1998) Rôle de l’exérèse chirurgicale en cas de réponse clinique complète (RCC) après chimiothérapie néo-adjuvante dans les cancers du sein supérieurs à 3 cm. Rev Fr Gynecol Obstet 93, 5: 379–85

    Google Scholar 

  12. Kaneyuki M, Takashi F, Toru W (2002) Concordance in pathological response to neoadjuvant chemotherapy between invasive and non invasive components of primary breast carcinomas. Breast Cancer, vol. 9(1): 75–81, ISSN: 1340-6868

    Article  Google Scholar 

  13. Kuerer HM, Sahin AA, Hunt KK et al. Incidence and Impact of Documented eradication of Breast Cancer Axillary Lymph Node Metastases Before Surgery in Patients Treated with Neoadjuvant Chemotherapy. Annals of Surgery, vol. 230, no 1, 72–8

    Google Scholar 

  14. Hennequin C, Espié M, Misset JL, Maylin C (2003) Does primary chemotherapy really increase the rate of breast conserving treatments ? Cancer/radiothérapie 8: 48–53

    Article  Google Scholar 

  15. Rouzier R, Mathieu MC, Sideris L et al. (2004) Breast-Conserving Surgery after Neoadjuvant Anthracycline-Based Chemotherapy for Large Breast American Cancer Society 2004 Cancer September 1, vol. 101, no 5

    Google Scholar 

  16. El Tamer M, Axiotis C, Kim E et al. (1999) Accurate prediction of the amount of in situ tumor in palpaable breast cancers by core needle biospe: implications for neoadjuvant therapy. Annals of Surgical Oncology 1999 Jul-Aug, vol. 6(5): 461–6, ISSN: 1068-9265

    Article  PubMed  Google Scholar 

  17. Mathieu MC, Rouzier R, Llombart-Cussac A et al. (2004) The poor responsiveness of infiltrating lobular breast carcinomas to neoadjuvant chemotherapy can be explained by their biological profile. European Journal of Cancer vol/I ss/pg. 40/3: 342–351, ISSN: 0959-8049

    Article  Google Scholar 

  18. Calitchi E, Kirova YM, Otmezguine Y et al. (2001) Long-Term Results of Neoadjuvant Radiation Therapy for Breast Cancer. J Cancer (Radiat Oncol Invest): 96, 253–9

    Article  CAS  Google Scholar 

  19. Danforth DN, Aloj L, Carrasquillo JA et al. (2002) The role of 18F-FDG-PET in the local/regional evaluation of women with breast cancer. Breast Cancer Research and Treatment 75: 135–46

    Article  PubMed  CAS  Google Scholar 

  20. Hieken TJ, Harrison J, Herreros J, Velasco JM (2001) Correlating sonography, mammography, and pathology in the assessment of breast cancer size. The American Journal of Surgery 182: 351–4

    Article  CAS  Google Scholar 

  21. Herrada J, Iyer RB, Atkinson EN et al. (1997) Relative Value of Physical Examination, Mammography, and Breast Sonography in Evaluating the Size of the Primary Tumor and Regional Lymph Node Metastases in Women Receiving Neoadjuvant Chemotherapy for Locally Advanced Breast Carcinoma. Clinical Cancer Research 1565 vol. 3: 1565–9, September 1997

    PubMed  CAS  Google Scholar 

  22. Rosen EL, Blackwell KL, Baker JA et al. (2003) Accuracy of MRI in the Detection of Residual Breast Cancer after Neoadjuvant Chemotherapy. AJR 181: 1275–82

    PubMed  Google Scholar 

  23. Balu-Maestro C, Chapellier C, Bleuse A et al. (2002) Imaging in evaluation of response to neoadjuvant breast cancer treatment benefits of MRI. Breast cancer research and treatment (Breast-Cancer-RES-Treat) 2002 Mar, vol. 72(2): 145–52, ISSN: 0167-6806

    Article  CAS  Google Scholar 

  24. Golshan M, Fung BB, Wiley E et al. (2004) Prediction of breast cancer size by ultrasound, mammography and core biopsy. Breast vol/iss/Pg. 13/4 5265–271, ISSN: 0960-9776

    Article  Google Scholar 

  25. Wasser K, Sinn HP, Fink C et al. (2003) Accuracy of tumor size measurement in breast cancer using MRI is influenced by histological regression induced by neoadjuvant chemotherapy. Eur Radiol 13: 1213–23

    PubMed  CAS  Google Scholar 

  26. Fadul D, Rapelyea J, Shwartz AM et al. (2004) Development of MalignantBreast Microcalcifications after Neoadjuvant Chemotherapy in Advanced Breast Cancer. The Breast Journal, vol. 10, no 2: 141–5

    Article  PubMed  Google Scholar 

  27. Sapino A, Cassoni P, Zanon E et al. (2003) Ultrasonographically-guided fine-needle aspiration of axillary lymph nodes: role in breast cancer management. Br J Cancer. 2003 Mar 10; 88(5): 702–6

    Article  PubMed  CAS  Google Scholar 

  28. Oruwari Jovita UN, Chung MA, Koelliker S et al. (2002) Axillary staging using ultrasound-guided fine needle aspiration biopsy in locally advanced breast cancer. The American Journal of Surgery 184: 307–9

    Article  CAS  Google Scholar 

  29. de Kanter AY, Van Eijck CH, Van Geel AN et al. (1999) Multicentre study of ultrasonographically guided axillary node biopsy in patients with breast cancer. Br J Surg. 1999 Nov; 86(11): 1459–62

    Article  PubMed  Google Scholar 

  30. Michel-Sven CA, Keller-Thomas M, Froelich-Johannes M et al. (2002) Preoperative breast cancer staging: MR imaging of the axilla withe ultrasmall superparamagnetic iron oxide enhancement. Radiology (Radiology) 2002 Nov, vol. 225(2): 527–36, ISSN: 0033-8419

    CAS  Google Scholar 

  31. Wahl RL, Siegel BA, Coleman RE, Gatsonis CG (2004) Prospective multicenter study of axillary nodal staging by positron emission tomography in breast cancer: a report ot the staging breast cancer with PET study group. J Clin Oncol 22: 277–85

    Article  PubMed  Google Scholar 

  32. Fehr MK, Hornung R, Vara Z et al. (2004) Axillary staging using positron emission tomography in breast cancer patients qualifying for sentinel node biopsy. The Breast J 10: 89–93

    Article  Google Scholar 

  33. Narducci F, Creutz V, Aubard Y et al. (2003) Sentinel-node biopsy in axillary lymph-node staging under local anaesthesia in breast cancer: Technical aspect. Bulletin du Cancer (01 Feb 2003, Vol/Iss/Pg. 90/2 5177–180), ISSN: 0007-4551

    Google Scholar 

  34. Schrenk P, Hochreiner G, Fridrik M, Wayand W (2003) Sentinel Node Biopsy Performed before Preoperative Chemotherapy for Axillary Lymph Node Staging in Breast Cancer. The Breast Journal, vol. 9, no 4: 282–7

    Article  PubMed  Google Scholar 

  35. Bellon JR, Livingston RB, Eubank WB et al. (2004) Evaluation of the internal mammary lymph nodes by FDG-PET in locally advanced breast cancer (LABC) American Journal of Clinical Oncology: Cancer Clinical Trials vol/Iss, 27/4: 407–10, ISSN: 0277-3732

    Google Scholar 

  36. Pierga JY, Mouret E, Laurence V et al. (2002) Prognostic factors for survival after neoadjuvant chemotherapy in operable breast cancer: the role of clinical reponse. European Journal of Cancer 39: 1089–96

    Article  Google Scholar 

  37. Cheung YC, Chen SC, Su MY et al. (2003) Monitoring the size and response of locally advanced breast cancers to neoadjuvant chemotherapy (weekly paclitaxel and epirubicin) with serial enhanced MRI. Breast Cancer Research and Treatment 78: 51–8

    Article  PubMed  CAS  Google Scholar 

  38. Wasser K, Sinn HP, Fink C et al. (2002) Accuracy of tumor size measurement in breat cancer using MRI is influenced by histological regression induced by neoadjuvant chemotherapy. Eur Radiol 13: 1213–23

    PubMed  Google Scholar 

  39. Kim SJ, Kim SK, Lee ES et al. (2004) Predictive value of [18F]FDG PET for pathological response of breast cancer to neo-adjuvant chemotherapy. Annals of Oncology 15: 1352–7

    Article  PubMed  Google Scholar 

  40. Ahr A, Karn T, Solbach C et al. (2002) Identification of high risk breast cancer patients by gene expression profiling. Lancet 359: 131–2

    Article  PubMed  Google Scholar 

  41. Arimappamagan A, Kadambari D, Srinivasan K et al. (2004) Complete Axillary Conversion after Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer: A step Towards Conserving Axilla? Indian Journal of Cancer/January-March 2004/ vol. 41 / Issue 1

    Google Scholar 

  42. Curé H, Amat S, Penault-Llorca F et al. (2002) Prognostic value of residual node involment in operable breast cancer after induction chemotherapy. Breast Cancer Research and Treatment 76: 37–45

    Article  PubMed  Google Scholar 

  43. Chollet P, Amat S, Cure H et al. (2002) Prognostic significance of a complete pathological response after induction chemotherapy in operable breast cancer. British Journal of Cancer 86: 1041–6

    Article  PubMed  CAS  Google Scholar 

  44. Dash N, Chafin SH, Johnson RR, Contractor FM (1999) Usefulness of Tissue Marker Clips in Patients Undergoing Neoadjuvant Chemotherapy for Breast Cancer AJR: 173, October 1999

    Google Scholar 

  45. Edeiken BS, Fornage BD, Bedi DG et al. (1999) US-guided Implantation of Metallic Markers for Permanent Localization of the Tumor Bed in Patients with Breast Cancer Who Undergo Preoperative Chemotherapy. Radiology (1999) 213: 895–900. British Journal of Cancer (2002) 86: 1041-6

    PubMed  CAS  Google Scholar 

  46. Kuerer HM, Singletary ES, Buzdar AU et al. (2001) Surgical conservation planning after neoadjuvant chemotherapy for stage II and operable stage III breast carcinoma. The American Journal of Surgery 182: 601–8

    Article  CAS  Google Scholar 

  47. Yeh KA, Jillella AP, Wei JP (2000) Surgery for T4 breast carcinoma: implications for local control. Am Sur 2000 Mar; 66(3): 250–4; discussion 255

    CAS  Google Scholar 

  48. Brown IM, Wilson CR, Doughty JC et al. Recurrence following skin sparing mastectomy and immediate breast reconstruction for breast cancer. Poster Session; Treatment; Surgery (7; 00 AM-9; 00 AM)

    Google Scholar 

  49. Sultan MR, Smith ML, Estabrook A et al. (1997) Immediate breast reconstruction in patients with locally advanced disease. Annals of Plastic Surgery, vol/iss: 38/4 5345–51, ISSN: 0148-7043

    Google Scholar 

  50. Deutsch MF, Smith M, Wang B et al. (1998) Immediate Breast Reconstruction with the TRAM Flap after Neoadjuvant Therapy. Ann Plast Surg 42: 240–4

    Google Scholar 

  51. Pendas S, Jakub J, Giuliano R (2004) The role of sentinel lymph node biopsy in Patients with ductal carcinoma in situ or with locally advanced breast cancer receiving neoadjuvant chemotherapy. Cancer control 231 July/August 2004, vol. 11, no 4

    Google Scholar 

  52. Nason KS, Anderson BO, Byrd DR et al. (2000) Increased false negative sentinel node biopsy rates after preoperative chemotherapy for invasive breast carcinoma. Cancer december 2001, 1, vol. 89, no 11

    Google Scholar 

  53. Cohen LF, Breslin TM, Kuerer HM et al. (2000) Identification and Evaluation of Axillary Sentinel Lymph Nodes in Patients with Breast Carcinoma Treated with Neoadjuvant Chemotherapy. The American Journal of Surgical Pathology 24(9): 1266–72

    Article  PubMed  CAS  Google Scholar 

  54. Penault-Lorca F, Vincent-Salomon A (2003) Roles of the pathologist in neoadjuvant chemotherapy: evaluation of response, prognostic and predictive factors. 7: Ann Pathol 2003 Dec; 23(6): 555–63. Related Articles, Links

    Google Scholar 

  55. Sataloff DM, Mason BA, Prestipino AJ et al. (1995) Pathologic response to induction chemotherapy in locally advanced carcinoma of the breast: a determinant of outcome 1: J Am Coll Surg. 1995 Mar; 180(3): 297–306

    PubMed  CAS  Google Scholar 

  56. Chevallier B, Mosseri V, Dauce JP et al. (1990) A prognostic score in histological node negative breast cancer. Br J Cancer Mar, 61(3): 436–40

    CAS  Google Scholar 

  57. Buchholz TA, Tucker SL, Masullo L et al. (2001) Predictors of Local-Regional Recurrence After Neoadjuvant Chemotherapy and Mastectomy Without Radiation. Journal of Clinical Oncology 20: 17–23. 2001 by American Society of Clinical Oncology

    Article  Google Scholar 

  58. Stearns V, Singh B, Tsangaris T et al. (2003). A Prospective Randomized Pilot Study to Evaluate Predictors of Response in Serial Core Biopsies to Single Agent Neoadjuvant Doxorubicin or Paclitaxel for Patients with locally Advanced Breast Cacner. Clinical Cancer Research, vol. 9, 124–133, January 2003

    PubMed  CAS  Google Scholar 

  59. Modlich O, Prisack HB, Munnes M et al. (2004) Immediate gene expression changes after the first course of neoadjuvant chemotherapy in patients with primary breast cancer disease. Clin Cancer Res 2004 Oct 1 (10), 6418–31

    Article  PubMed  CAS  Google Scholar 

  60. Nowak AK, Wilcken NRC, Stockler MR et al. (2004) Systematic review of taxane-containing versus non-taxane-containing regimens for adjuvant and neoadjuvant treatment of early breast cancer. Lancet Oncol 5: 372–80

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Gynécologie Obstétrique, Université Paris VI, Cancerest, Hôpital Tenon, 4, rue de la Chine, 75020, Paris

    S. Uzan

  2. Cancerest, Hôpital Tenon, Université Paris VI, 4, rue de la Chine, 75020, Paris

    M. Antoine, E. Barranger, J. -F. Bernaudin, J. Chopier, E. Daraï, D. Grahek, J. -Y. Seror & E. Touboul

  3. Oncologie Médicale, CancerEst, Hôpital Tenon, Assistance publique-Hôpitaux de Paris, Université Paris VI, 4, rue de la Chine, 75020, Paris

    J. Gligorov

  4. Amicale Franco Macédonienne Oncologique, Skopje, Macédoine

    J. Gligorov

  5. Oncologie médicale, Université Paris VI, Cancerest, Hôpital Tenon, 4, rue de la Chine, 75020, Paris

    J. -P. Lotz

Authors
  1. S. Uzan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Antoine
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. E. Barranger
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. J. -F. Bernaudin
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. J. Chopier
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. E. Daraï
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. D. Grahek
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. J. Gligorov
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. J. -P. Lotz
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. J. -Y. Seror
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. E. Touboul
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer-Verlag France, Paris

About this paper

Cite this paper

Uzan, S. et al. (2006). Prise en charge chirurgicale des patientes traitées par chimiothérapie néo-adjuvante pour cancer du sein. In: Cancer du sein. Springer, Paris. https://doi.org/10.1007/2-287-31109-2_18

Download citation

  • DOI: https://doi.org/10.1007/2-287-31109-2_18

  • Publisher Name: Springer, Paris

  • Print ISBN: 978-2-287-25174-0

  • Online ISBN: 978-2-287-31109-3

Publish with us

Policies and ethics

Search

Navigation